Reporter brief
The Benefits of Nicotinamide Riboside Upon Cognition and Sleep in Older Veterans
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- No results are reported; this appears to be a protocol or proposal rather than a completed trial with outcomes. The mechanism proposed (NAD+ → BDNF → improved cognition and sleep) is theoretical and cannot be evaluated from this abstract. The study design and population (older veterans) are described but actual findings cannot be assessed from the information provided.
Study design and sample
Rct; Human.
Older adults, specifically identified as older veterans
- Design
- Rct
- Sample
- —
- Journal
- State University of New York at Buffalo
- Published
- Sep 24, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Nicotinamide riboside timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.